NCT06322251 Identification of Interpesonal Violence
| NCT ID | NCT06322251 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Region Stockholm |
| Condition | Primary Health Care |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-04-01 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2024-04-01 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to increase primary care professional's ability to identify individuals exposed to intimate partner violence (IPV) in primary health care settings. The main questions it aims to answer are 1. To what extent do the following three interventions contribute to identify potential victims of IPV: (1) the use of a standardized questionnaire that screens exposure to IPV, (2) staff using tailored virtual patients for clinical training on IPV and (3) a combination of interventions 1 and 2? 2. Which intervention do primary care professionals experience as most effective in increasing the ability to identify and respond to victims of IPV? Participants will be divided to apply one of the three interventions in their health care setting: 1) a standardized questionnaire to patients, 2) virtual patients tailored to health professionals, and 3) a combination of 1 and 2. Pre-and post-measurement of the health professionals identification of patients exposed to IPV will will be used to explore the effect of the interventions. Focus group interviews with the participating health professionals will be a qualitative complement. The participants will be asked about what intervention they experience as the most effective in increasing the ability to identify victims of IPV.
Eligibility Criteria
Inclusion criteria: * All health care staff who meet patients at the included study sites are elegible for the study * Midwives, MDs, psychologists, social workers, nurses etc. Exclusion criteria: \- Health care staff who does not want to participate
Contact & Investigator
Mia M Barimani, Professor
PRINCIPAL INVESTIGATOR
Linkoeping University
Frequently Asked Questions
Who can join the NCT06322251 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Primary Health Care. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06322251 currently recruiting?
Yes, NCT06322251 is actively recruiting participants. Contact the research team at mia.barimani@liu.se for enrollment information.
Where is the NCT06322251 trial being conducted?
This trial is being conducted at Linköping, Sweden.
Who is sponsoring the NCT06322251 clinical trial?
NCT06322251 is sponsored by Region Stockholm. The principal investigator is Mia M Barimani, Professor at Linkoeping University. The trial plans to enroll 200 participants.